Bellevue Group Ag Abbott Laboratories Transaction History

Bellevue Group Ag

$5.93 Billion
Q3 2024

A detailed history of Bellevue Group Ag transactions in Abbott Laboratories stock. As of the latest transaction made, Bellevue Group Ag holds 1,743,938 shares of ABT stock, worth $200 Million. This represents 3.35% of its overall portfolio holdings.

Number of Shares

1,743,938

Previous 1,606,153 8.58%

Holding current value

$200 Million

Previous $167 Million 19.13%

% of portfolio

3.35%

Previous 2.79%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$100.07 - $118.13 $13.8 Million - $16.3 Million	137,785 Added 8.58%	1,743,938 $199 Million
Q2 2024 Aug 14, 2024	BUY	$100.73 - $112.44 $17.3 Million - $19.3 Million	171,970 Added 11.99%	1,606,153 $167 Million
Q1 2024 May 15, 2024	SELL	$109.52 - $120.96 $11.1 Million - $12.3 Million	-101,473 Reduced 6.61%	1,434,183 $163 Million
Q4 2023 Feb 14, 2024	SELL	$90.19 - $110.4 $2.28 Million - $2.79 Million	-25,312 Reduced 1.62%	1,535,656 $169 Million
Q3 2023 Nov 14, 2023	SELL	$95.53 - $114.62 $8.17 Million - $9.8 Million	-85,533 Reduced 5.19%	1,560,968 $151 Million
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $41,823 - $46,600	-415 Reduced 0.03%	1,646,501 $180 Million
Q1 2023 May 15, 2023	SELL	$96.86 - $114.01 $3.64 Million - $4.28 Million	-37,563 Reduced 2.23%	1,646,916 $167 Million
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $10.9 Million - $12.8 Million	114,628 Added 7.3%	1,684,479 $185 Million
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $382,782 - $443,190	-3,956 Reduced 0.25%	1,569,851 $152 Million
Q2 2022 Aug 11, 2022	SELL	$102.07 - $123.37 $5.01 Million - $6.06 Million	-49,120 Reduced 3.03%	1,573,807 $171 Million
Q1 2022 May 13, 2022	SELL	$114.02 - $139.04 $14 Million - $17.1 Million	-122,874 Reduced 7.04%	1,622,927 $192 Million
Q4 2021 Feb 10, 2022	BUY	$115.53 - $141.46 $41.4 Million - $50.7 Million	358,302 Added 25.82%	1,745,801 $246 Million
Q3 2021 Nov 12, 2021	BUY	$116.66 - $129.06 $1.17 Million - $1.29 Million	10,000 Added 0.73%	1,387,499 $164 Million
Q2 2021 Aug 12, 2021	SELL	$105.79 - $124.53 $1.64 Million - $1.93 Million	-15,500 Reduced 1.11%	1,377,499 $160 Million
Q1 2021 May 12, 2021	SELL	$108.84 - $128.23 $421,646 - $496,763	-3,874 Reduced 0.28%	1,392,999 $167 Million
Q4 2020 Feb 16, 2021	BUY	$105.0 - $114.42 $11.4 Million - $12.4 Million	108,588 Added 8.43%	1,396,873 $153 Million
Q3 2020 Nov 16, 2020	BUY	$91.64 - $111.29 $367,751 - $446,606	4,013 Added 0.31%	1,288,285 $140 Million
Q1 2020 May 14, 2020	SELL	$62.82 - $91.86 $2.58 Million - $3.78 Million	-41,148 Reduced 3.1%	1,284,272 $101 Million
Q4 2019 Feb 14, 2020	BUY	$78.51 - $87.4 $17.8 Million - $19.9 Million	227,306 Added 20.7%	1,325,420 $115 Million
Q3 2019 Nov 14, 2019	BUY	$81.84 - $88.74 $11.5 Million - $12.5 Million	140,519 Added 14.67%	1,098,114 $91.9 Million
Q2 2019 Aug 14, 2019	SELL	$72.88 - $85.0 $6.05 Million - $7.05 Million	-82,992 Reduced 7.98%	957,595 $80.5 Million
Q1 2019 May 15, 2019	BUY	$66.22 - $80.06 $4.25 Million - $5.13 Million	64,136 Added 6.57%	1,040,587 $83.2 Million
Q4 2018 Feb 12, 2019	BUY	$65.56 - $74.27 $13.8 Million - $15.6 Million	209,741 Added 27.36%	976,451 $70.6 Million
Q3 2018 Nov 13, 2018	BUY	$60.81 - $73.36 $12 Million - $14.5 Million	197,860 Added 34.78%	766,710 $56.2 Million
Q2 2018 Aug 07, 2018	BUY	$57.57 - $63.54 $221,644 - $244,629	3,850 Added 0.68%	568,850 $34.7 Million
Q1 2018 May 09, 2018	BUY	$56.27 - $63.62 $1.97 Million - $2.23 Million	35,000 Added 6.6%	565,000 $33.9 Million
Q4 2017 Feb 14, 2018	BUY	$53.68 - $57.47 $1.45 Million - $1.55 Million	27,000 Added 5.37%	530,000 $30.2 Million
Q3 2017 Nov 13, 2017	BUY	$48.06 - $53.64 $2.88 Million - $3.22 Million	60,000 Added 13.54%	503,000 $26.8 Million
Q2 2017 Aug 14, 2017	BUY	N/A	443,000	443,000 $21.5 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.

Account

Bellevue Group Ag Abbott Laboratories Transaction History